COMBINATIONS OF THE CYTOKINES IL-12, IL-2 AND IFN-α SIGNIFICANTLY AUGMENT WHEREAS THE CYTOKINE IL-4 SUPPRESSES THE CYTOKINE-INDUCED ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY OF MONOCLONAL ANTIBODIES 17-1A AND BR55-2

Author： Flieger D. Spengler U. Beier I. Sauerbruch T. Schmidt-Wolf I.

Publisher： Academic Press

ISSN： 1043-4666

Source： Cytokine, Vol.12, Iss.6, 2000-06, pp. : 756-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Since some cytokines effectively enhance the cytotoxicity of monoclonal antibodies, we investigated whether a combination of cytokines can augment the antibody-dependent cellular cytotoxicity (ADCC) of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29. Since monocytes/macrophages are important effector cells for ADCC, we used a new flow cytometric cytotoxicity assay, which allows the analysis of long-term-ADCC exerted by these cells. In our previous studies with peripheral blood mononuclear cells from normal donors, we found that IL-2, IL-12 and IFN-α increase ADCC. Therefore, we examined whether combination of these three cytokines with IL-2, IL-4, IL-6, IL-10, IL-12, IFN-α, IFN-γ, GM-CSF, M-CSF and TNF-α may yield higher ADCC than obtained by the application of single cytokines. Indeed, we found that the combinations IL-2/IFN-α, IL-2/IL-12 and IL-12/IFN-α potentiated ADCC. Interestingly, the ineffective single cytokines TNF-α and GM-CSF in the combinations IL-2/TNF-α, IFN-α/TNF-α and IFN-α/GM-CSF also proved to enhance ADCC. In contrast, IL-4 significantly suppressed the IL-2, IL-12 and IFN-α-induced ADCC. In addition, the immunosuppressive cytokine IL-10 in higher concentrations significantly suppressed the IL-12-induced-ADCC. Our results may be useful to find combinations of cytokines and mAb for the treatment of cancer.